CRIL

Cambridge, United Kingdom Founded: 2018 • Age: 8 yrs
AI-assisted devices for cell analysis and tissue diagnosis are developed.

About CRIL

CRIL is a company based in Cambridge (United Kingdom) founded in 2018 by Giulio Cerullo. CRIL has raised $1.7 million across 8 funding rounds from investors including Frontier IP, European Union and Graphene Flagship. The company has 1 employees. CRIL offers products and services including STRALE, CHAMP, and CORAL. CRIL operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 1
  • Founders Giulio Cerullo
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website cambridgeramanimaging.com
  • Social LinkedIn Facebook
  • Legal Name Cambridge Raman Imaging Ltd
  • Date of Incorporation 15 Mar, 2018
  • Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM
Key Metrics
  • Total Equity Funding
    $1.7M (USD)

    in 8 rounds

  • Latest Funding Round
    $1.38M (USD), Seed

    May 2022

  • Investors
  • Employee Count
    1

Products & Services of CRIL

CRIL offers a comprehensive portfolio of products and services, including STRALE, CHAMP, and CORAL.

STRALE
Laser Imaging System

Ultra-fast laser for coherent Raman imaging in tissue analysis.

CHAMP
Microscopy Product

Advanced tool for high-speed label-free cell diagnostics.

CORAL
Imaging Technology

Platform for AI-assisted Raman scattering microscopy applications.

Funding Insights of CRIL

CRIL has successfully raised a total of $1.7M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $1.38 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.7M
  • Total Rounds 8
  • Last Round Seed β€” $1.38M
  • First Round $151,317

    (Feb 2020)

  • Investors Count 3

All 8 funding rounds of CRIL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$1.38MSeed––
May 2022$119,356Debt – Conventional––
–
Dec 2020$829,098Grant––
Oct 2020–Grant––
Jul 2020$314,100Seed––
–
Jul 2020–Seed––
–
Apr 2020–Grant––
Feb 2020$151,317Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in CRIL

CRIL has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Frontier IP, European Union and Graphene Flagship.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Asset management consulting services are provided by Frontier IP.
2009frontierip.co.ukEdinburgh, United Kingdom
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Research and innovation in graphene and 2D materials are facilitated.
–graphene-flagship.eu-
Premium access

Investor details for CRIL

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CRIL

1 people are tracked at CRIL (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Giulio Cerullo
Co-FounderLeadership
Premium access

Complete people profiles for CRIL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CRIL

3 dated milestones of CRIL across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded CRIL is founded.
  2. Funding First funding round of $151K.
  3. Funding Latest funding round, Seed, of $1.4M.

Competitors of CRIL

CRIL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
oxinst.com1959Abingdon, United Kingdom–2,027
Technology tools and systems for molecular scale are developed.
leica-microsystems.com1914Wetzlar, Germany–67
Imaging solutions for macro, micro, and nano structures are provided.
iba-worldwide.com1986–$27.32M–
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
scholarrock.com2012Cambridge, United States$103.3M150
Antibody-based drugs for primary myopathies are developed and targeted.
spectrawave.com2012Waltham, United States$79.88M36
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
fluxionbio.com2005San Francisco, United States$20.85M–
Microfluidics-based tools for cellular analysis are provided.
metrohm.com1943Herisau, Switzerland–608
Instruments for chemical analysis are developed and manufactured.
ionpath.com2014Menlo Park, United States$18M37
Multiplexed ion beam imaging platform for tissue biopsies is developed.
samantree.com2014Lausanne, Switzerland$33.78M–
A surgical digital microscope for tumor resection is developed.
phasefocus.com2006Sheffield, United Kingdom$12.08M10
Provider of virtual lens that generates High definition images without high-quality lenses
Premium access

Detailed competitors of CRIL

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CRIL

The website of CRIL (cambridgeramanimaging.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 9.9% vs previous month

Latest news on Cril

Premium access

Complete news archive for CRIL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to CRIL

10 companies that operate in the same segment as CRIL (Imaging Diagnostics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Handheld ultrasound devices are developed for whole-body medical imaging.
2011Guilford, Connecticut, United StatesUSD 350 MUSD 97.61 M190
Technology tools and systems for molecular scale are developed.
1959Abingdon, Oxfordshire, United Kingdom–USD 648.1 M–
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.17 M–242
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Ultrasound images are analyzed via AI-based software provided by Exo.
2015Redwood City, California, United StatesUSD 463.39 M––
Planar X-ray radiology products for diagnostic imaging are supplied.
2000Oxford, Oxfordshire, United KingdomUSD 43.43 MUSD 1.04 M50
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
2007Los Angeles, California, United StatesUSD 59.64 M––
Portable wireless ultrasound systems are developed for medical imaging.
2014Burnaby, British Columbia, CanadaUSD 21.87 M––
Portable MRI systems are manufactured for medical professionals.
2014New York, New York, United States–USD 13.56 M111
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about CRIL

CRIL was founded in 2018 and raised its 1st funding round 2 years after it was founded.

CRIL is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

CRIL is a funded company, having raised a total of $1.7M across 8 funding rounds to date. The company's 1st funding round was a Grant of $151.32K, raised on Feb 2020.

CRIL has 1 employees.

CRIL was founded in 2018 in Cambridge, United Kingdom. Devices incorporating AI for cell analysis and tissue diagnosis are developed by the company within the biotechnology sector. The Coherent Raman Platform serves as a digital imaging tool to assess images used in diagnosis, cellular process evaluation, drug discovery, and therapy monitoring. Operations center on medical imaging applications for research and clinical settings.

CRIL's top competitors include Oxford Instruments, Scholar Rock and Leica Microsystems.

CRIL offers STRALE, CHAMP, and CORAL.

CRIL has 3 investors. Key investors include Frontier IP, European Union, and Graphene Flagship.

CRIL operates through Cambridge Raman Imaging Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available